We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
(+6.2%)
Cap. Flow
-$64.1M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$14.8M |
| 2 |
Henry Schein
HSIC
|
+$14.3M |
| 3 |
Honeywell
HON
|
+$14.2M |
| 4 |
Pediatrix Medical
MD
|
+$13.5M |
| 5 |
Charles River Laboratories
CRL
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.1M |
| 2 |
CVS Health
CVS
|
+$18M |
| 3 |
Accendra Health
ACH
|
+$14.8M |
| 4 |
Ubiquiti
UI
|
+$13.1M |
| 5 |
Eagle Bancorp
EGBN
|
+$11.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.91% |
| 2 | Healthcare | 16.24% |
| 3 | Technology | 15.4% |
| 4 | Industrials | 13.98% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Waste Management
WM
$90.7B
| $208K | ﹤0.01% |
+2,407
| New | +$196K |
2017 Q4
0 quarters
|
|
377
Cummins
CMI
$73.1B
| $207K | ﹤0.01% |
+1,170
| New | +$200K |
2017 Q4
0 quarters
|
|
378
Xylem
XYL
$24.3B
| $206K | ﹤0.01% |
+3,016
| New | +$200K |
2017 Q4
0 quarters
|
|
379
Citigroup
C
$208B
| $204K | ﹤0.01% |
+2,744
| New | +$203K |
2017 Q4
0 quarters
|
|
380
McKesson
MCK
$117B
| $204K | ﹤0.01% |
1,308
-168
| -11% | -$24.9K |
2013 Q3
17 quarters
|
|
381
Sherwin-Williams
SHW
$81.4B
| $202K | ﹤0.01% |
+1,476
| New | +$194K |
2017 Q4
0 quarters
|
|
382
Blackrock
BLK
$176B
| $201K | ﹤0.01% |
+391
| New | +$190K |
2017 Q4
0 quarters
|
|
383
iShares Core S&P Small-Cap ETF
IJR
$102B
| $201K | ﹤0.01% |
+2,620
| New | +$198K |
2017 Q4
0 quarters
|
|
384
DELISTED
Brookline Bancorp
BRKL
| $157K | ﹤0.01% |
10,000
| – | – |
2016 Q2
6 quarters
|
|
|
385
Eagle Bancorp
EGBN
$864M
| – | – |
-170,288
| Closed | -$11.4M | – |
|
386
Graco
GGG
$13.3B
| – | – |
-31,500
| Closed | -$1.3M | – |
|
387
The Kraft Heinz Company
KHC
$28.1B
| – | – |
-2,921
| Closed | -$227K | – |
|
|
388
Accendra Health
ACH
$18.1M
| – | – |
-506,011
| Closed | -$14.8M | – |
|
389
Toro Company
TTC
$9.52B
| – | – |
-18,545
| Closed | -$1.15M | – |
|
|
390
Ubiquiti
UI
$36.4B
| – | – |
-232,980
| Closed | -$13.1M | – |
|
391
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-705,936
| Closed | -$10.1M | – |
|
|
ANDV
392
DELISTED
Andeavor
ANDV
| – | – |
-22,646
| Closed | -$2.33M | – |
|
393
DELISTED
Calgon Carbon Corp
CCC
| – | – |
-528,690
| Closed | -$11.3M | – |
|
|
BCR
394
DELISTED
CR Bard Inc.
BCR
| – | – |
-193,872
| Closed | -$62.1M | – |
|
Similar funds
Boston Trust Walden's Q4 2017 Portfolio in Review
As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
- Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
- Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
- Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
- Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
- Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
- Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.
Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.